J2787 – Riboflavin 5'-phosphate, ophthalmic solution (photrexa viscous/photrexa), up to 3 ml
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ2787
- Long description
- Riboflavin 5'-phosphate, ophthalmic solution (photrexa viscous/photrexa), up to 3 ml
- Short description
- Riboflavin photrexa/viscous
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- Added
- January 1, 2019
- Last change
- July 1, 2026 – No change
Frequently asked questions
What is HCPCS code J2787?
J2787 is a HCPCS Level II code for riboflavin 5'-phosphate, ophthalmic solution (photrexa viscous/photrexa), up to 3 ml.
Does Medicare cover J2787?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J2778 – Injection, ranibizumab, 0.1 mg
- J2779 – Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg
- J2780 – Injection, ranitidine hydrochloride, 25 mg
- J2781 – Injection, pegcetacoplan, intravitreal, 1 mg
- J2782 – Injection, avacincaptad pegol, 0.1 mg
- J2783 – Injection, rasburicase, 0.5 mg
- J2785 – Injection, regadenoson, 0.1 mg
- J2786 – Injection, reslizumab, 1 mg
- J2788 – Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)
- J2789 – Riboflavin 5'-phosphate, ophthalmic solution (epioxahd/epioxa), up to 2 ml
- J2790 – Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)
- J2791 – Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu
- J2792 – Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu
- J2793 – Injection, rilonacept, 1 mg
- J2794 – Injection, risperidone (risperdal consta), 0.5 mg
- J2795 – Injection, ropivacaine hydrochloride, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.